Back to All Studies

Sepsis, a severe bacterial infection, is a leading cause of death in foals in their first weeks of life and new strategies are needed to help save these young patients. Researchers will study the effects of a novel adjunct therapeutic strategy coined “metabolic resuscitation” – a combination treatment of hydrocortisone, thiamin and vitamin C – and its potential to reduce inflammation and improve outcomes for septic foals. Recent studies report nearly one-third less deaths when this treatment combination is administered to septic human patients in conjunction with standard-of-care treatment. Researchers will gather preliminary data to evaluate the metabolic resuscitation strategy and its potential to improve survival rates of septic foals. 

Study ID
D19EQ-025
Study Status
Active
Start Date
02/01/2019
Grant amount awarded
$147,390
Grant recipient
The University of Georgia
Study country
United States
Investigator
Kelsey A. Hart, DVM, DACVIM
Study category
Immunology